|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 591 active entries
Willem Schoutenstraat 1
1057 DL Amsterdam The Netherlands
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
MRC Holland is the inventor and manufacturer of Multplex-ligation dependent Probe Amplification, or MLPA. MLPA® is a method that can detect copy number changes of up to 50 nucleic acid sequences in one simple reaction. MLPA® quickly identifies amplifications and deletions of a large number of genes, and can be used for DNA and mRNA profiling of both blood and tumour-derived samples. Furthermore, the MLPA® method can also be used to analyse CpG-methylation (MS-MLPA®). MLPA® has rapidly established its reputation as a trustworthy and efficient method. Hundreds of publications about the technique have appeared since its introduction in 2002, and MLPA® is now used in more than 900 laboratories worldwide.
Last update of this entry: September 29, 2015
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking